BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16545382)

  • 1. Putative aggregation initiation sites in prion protein.
    Ziegler J; Viehrig C; Geimer S; Rösch P; Schwarzinger S
    FEBS Lett; 2006 Apr; 580(8):2033-40. PubMed ID: 16545382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy.
    Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K
    Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
    Surewicz WK; Jones EM; Apetri AC
    Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A molecular dynamics approach to the structural characterization of amyloid aggregation.
    Cecchini M; Curcio R; Pappalardo M; Melki R; Caflisch A
    J Mol Biol; 2006 Apr; 357(4):1306-21. PubMed ID: 16483608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of possible prion protein self-interaction domains using peptide arrays.
    Rigter A; Langeveld JP; Timmers-Parohi D; Jacobs JG; Moonen PL; Bossers A
    BMC Biochem; 2007 Apr; 8():6. PubMed ID: 17430579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterization of beta-sheeted oligomers formed on the pathway of oxidative prion protein aggregation in vitro.
    Redecke L; von Bergen M; Clos J; Konarev PV; Svergun DI; Fittschen UE; Broekaert JA; Bruns O; Georgieva D; Mandelkow E; Genov N; Betzel C
    J Struct Biol; 2007 Feb; 157(2):308-20. PubMed ID: 17023178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism for low pH triggered misfolding of the human prion protein.
    DeMarco ML; Daggett V
    Biochemistry; 2007 Mar; 46(11):3045-54. PubMed ID: 17315950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fast, reversible interaction of prion protein with RNA aptamers containing specific sequence patterns.
    Mercey R; Lantier I; Maurel MC; Grosclaude J; Lantier F; Marc D
    Arch Virol; 2006 Nov; 151(11):2197-214. PubMed ID: 16799875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural properties of prion protein protofibrils and fibrils: an experimental assessment of atomic models.
    DeMarco ML; Silveira J; Caughey B; Daggett V
    Biochemistry; 2006 Dec; 45(51):15573-82. PubMed ID: 17176078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous beta-helical fold in prion protein: the case of PrP(82-146).
    Saracino GA; Villa A; Moro G; Cosentino U; Salmona M
    Proteins; 2009 Jun; 75(4):964-76. PubMed ID: 19089953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clustered negative charges on the lipid membrane surface induce beta-sheet formation of prion protein fragment 106-126.
    Miura T; Yoda M; Takaku N; Hirose T; Takeuchi H
    Biochemistry; 2007 Oct; 46(41):11589-97. PubMed ID: 17887730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prion paradox: infection or polymerisation?
    Biro JC
    Appl Bioinformatics; 2003; 2(3 Suppl):S25-30. PubMed ID: 15130813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of phosphorus dendrimers on the aggregation of the prion peptide PrP 185-208.
    Klajnert B; Cortijo-Arellano M; Cladera J; Majoral JP; Caminade AM; Bryszewska M
    Biochem Biophys Res Commun; 2007 Dec; 364(1):20-5. PubMed ID: 17927954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photo-induced crosslinking of prion protein oligomers and prions.
    Piening N; Weber P; Högen T; Beekes M; Kretzschmar H; Giese A
    Amyloid; 2006 Jun; 13(2):67-77. PubMed ID: 16911960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PrP N-terminal domain triggers PrP(Sc)-like aggregation of Dpl.
    Erlich P; Cesbron JY; Lemaire-Vieille C; Curt A; Andrieu JP; Schoehn G; Jamin M; Gagnon J
    Biochem Biophys Res Commun; 2008 Jan; 365(3):478-83. PubMed ID: 17997980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The organization and assembly of a beta-sheet formed by a prion peptide in solution: an isotope-edited FTIR study.
    Silva RA; Barber-Armstrong W; Decatur SM
    J Am Chem Soc; 2003 Nov; 125(45):13674-5. PubMed ID: 14599201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
    Walsh P; Simonetti K; Sharpe S
    Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model for prion protein dimerisation based on alpha-helical packing.
    Warwicker J; Gane PJ
    Biochem Biophys Res Commun; 1996 Sep; 226(3):777-82. PubMed ID: 8831689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly.
    Sjöberg AP; Nyström S; Hammarström P; Blom AM
    Mol Immunol; 2008 Jun; 45(11):3213-21. PubMed ID: 18406463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.